Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 280, pseudogene (RNU6-280P) is a *pseudogene*—a non-functional genomic DNA segment—related to the U6 family of small nuclear RNAs (snRNAs)[1][5]. U6 snRNAs are non-coding RNAs that serve an essential role in the spliceosome complex, which catalyzes the removal of introns from pre-mRNA during RNA splicing; however, RNU6-280P lacks the ability to be expressed as a functional snRNA or to assemble into spliceosomal complexes[3][4][5]. Many pseudogenes for U6 snRNA exist in the human genome, reflecting the evolutionary importance and repetitive nature of this gene family. RNU6-280P is not considered a protein, enzyme, receptor, or therapeutic target and does not have direct functional, disease, or pharmacological relevance[1][5]. Summary of application: RNU6-280P is a non-coding RNA pseudogene, included in genome annotations for reference but not as a functional gene, disease gene, or drug target. It is most relevant for genome studies and bioinformatics, not for therapeutic or diagnostic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 280, pseudogene (RNU6-280P).